| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
1996-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9b61131206d291c786dff762c8b65d6 |
| publicationDate |
1997-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H09278670-A |
| titleOfInvention |
Oral preparation of insulin-like growth factor 1 |
| abstract |
(57) Abstract: [PROBLEMS] To provide an IGF-1 preparation in a dosage form capable of absorbing insulin-like growth factor 1 (hereinafter referred to as IGF-1) in a simple amount and capable of exerting a sufficient drug effect. . SOLUTION: A preparation for oral administration containing IGF-1, Preferably, the oral administration preparation further contains an IGF-1 absorption promoting aid and / or an IGF-1 degradation inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103478707-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1021167-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7923025-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03059389-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1021167-A4 |
| priorityDate |
1995-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |